Evidence map›Paper›PMID 39099783›Full record

ArticleFrontiers in neurology2024

Higher incidence of acute symptomatic seizures in probable antibody-negative pediatric autoimmune encephalitis than in major antibody-positive autoimmune encephalitis.

Naoki Yamada, Takeshi Inoue, Ichiro Kuki, Naohiro Yamamoto, Masataka Fukuoka, Megumi Nukui, Hideo Okuno, Junichi Ishikawa, Kiyoko Amo, Masao Togawa and 2 more

Abstract read
In one paragraph

Article in Frontiers in neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Naoki YamadaDepartment of Pediatric Neurology and Logopedics, Osaka City General Hospital, Osaka, Japan.
Takeshi InoueDepartment of Pediatric Neurology and Logopedics, Osaka City General Hospital, Osaka, Japan.
Ichiro KukiDepartment of Pediatric Neurology and Logopedics, Osaka City General Hospital, Osaka, Japan.
Naohiro YamamotoDepartment of Pediatric Neurology and Logopedics, Osaka City General Hospital, Osaka, Japan.
Masataka FukuokaDepartment of Pediatric Neurology and Logopedics, Osaka City General Hospital, Osaka, Japan.
Megumi NukuiDepartment of Pediatric Neurology and Logopedics, Osaka City General Hospital, Osaka, Japan.
Hideo OkunoDepartment of Pediatric Emergency, Infectious Disease Internal Medicine, Osaka City General Hospital, Osaka, Japan.
Junichi IshikawaDepartment of Pediatric Emergency, Infectious Disease Internal Medicine, Osaka City General Hospital, Osaka, Japan.
Kiyoko AmoDepartment of Pediatric Emergency, Infectious Disease Internal Medicine, Osaka City General Hospital, Osaka, Japan.
Masao TogawaDepartment of Pediatric Emergency, Infectious Disease Internal Medicine, Osaka City General Hospital, Osaka, Japan.
Hiroshi SakumaDepartment of Brain and Neuroscience, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
Shin OkazakiDepartment of Pediatric Neurology and Logopedics, Osaka City General Hospital, Osaka, Japan.

Funding

Wellcome Trust FC001039
6 · The paper itself

Abstract

Purpose: To delineate the characteristics of probable antibody-negative pediatric autoimmune encephalitis (probable Ab-negative AE), we compared the clinical features of probable Ab-negative AE to those of major antibody-positive AE. Methods: We retrospectively reviewed the clinical features of 18 patients with probable Ab-negative AE, 13 with anti-N-methyl-D-aspartate receptor encephalitis (NMDARE), and 13 with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). Clinical characteristics, neuroimaging findings, treatments, and outcomes were analyzed. Results: The age of onset and length of hospital stay were significantly higher in the NMDARE group than in the other groups ( Conclusion: Patients with probable Ab-negative AE exhibited acute symptomatic seizures as initial neurological symptoms significantly more frequently. They developed autoimmune-associated epilepsy more frequently than those with NMDARE and MOGAD, which was not statistically significant. SPECT within 1 month of disease onset might be a valuable surrogate marker of ongoing neuroinflammation and neuronal dysfunction, even in patients with negative MRI findings.

Indexed as

antibody-negativeautoimmune encephalitisepilepsypediatricseizure

Identifiers

PMID39099783
PMCPMC11294254

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.